Everest Management Corp’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$613K Sell
511
-165
-24% -$169K 0.23% 45
2026
Q1
$622K Buy
676
+251
+59% +$254K 0.32% 41
2025
Q4
$457K Sell
425
-1
-0.2% -$956 0.25% 43
2025
Q3
$325K Sell
426
-4
-0.9% -$2.98K 0.21% 46
2025
Q2
$335K Buy
430
+4
+0.9% +$3.11K 0.24% 47
2025
Q1
$352K Buy
426
+48
+13% +$39.9K 0.32% 35
2024
Q4
$292K Buy
+378
New +$313K 0.26% 37

Other funds holding LLY

Everest Management Corp's LLY Position: Q2 2026 in Review

Everest Management Corp reduced its Eli Lilly (LLY) stake by 24% in Q2 2026, selling an estimated $169K and leaving 511 shares worth $613K. The position accounts for 0.23% of the portfolio, ranked #45.

Everest Management Corp first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. The position peaked at $622K in Q1 2026. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Everest Management Corp held 511 shares of Eli Lilly worth $613K as of Q2 2026.
  • Everest Management Corp sold 165 Eli Lilly shares in Q2 2026, an estimated $169K.
  • Eli Lilly made up 0.23% of Everest Management Corp's portfolio in Q2 2026, its #45 holding.
  • Everest Management Corp first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • Everest Management Corp's Eli Lilly position peaked at $622K in Q1 2026.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Everest Management Corp's 13F filing for Q2 2026, filed 7 Aug 2026.